CliffBio
small molecule

SODIUM BICARBONATE

SODIUM BICARBONATE

Loss of exclusivity—loss of exclusivity
CompanyExela Pharma Sciences Llc →See this company's full patent-cliff portfolio

Drug detail

Brand nameSODIUM BICARBONATE
Active ingredientSODIUM BICARBONATE
Strength44.6MEQ/50ML (0.9MEQ/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalJune 2019
Marketing statusRX

More from Exela Pharma Sciences Llc

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.